Lombard Odier Asset Management (Europe)’s Evolent Health EVH Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-175,000	Closed	-$1.97M	–	165
2024 Q4	$1.97M	Hold	175,000	–	–	0.13%	159
2024 Q3	$4.95M	Sell	175,000 -25,000	-13%	-$644K	0.21%	150
2024 Q2	$3.82M	Buy	200,000 +187,000	+1,438%	+$4.78M	0.18%	150
2024 Q1	$426K	Hold	13,000	–	–	0.03%	210
2023 Q4	$429K	Sell	13,000 -3,000	-19%	-$84.9K	0.02%	217
2023 Q3	$436K	Hold	16,000	–	–	0.02%	226
2023 Q2	$485K	Sell	16,000 -2,000	-11%	-$64.7K	0.02%	229
2023 Q1	$584K	Sell	18,000 -2,500	-12%	-$79.1K	0.03%	248
2022 Q4	$576K	Sell	20,500 -4,500	-18%	-$129K	0.02%	252
2022 Q3	$898K	Sell	25,000 -8,000	-24%	-$282K	0.05%	228
2022 Q2	$1.01M	Buy	+33,000	New	+$962K	0.05%	212

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s EVH Position: Q1 2025 in Review

Lombard Odier Asset Management (Europe) sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 175,000 shares — an estimated $1.97M sold.

Lombard Odier Asset Management (Europe) first reported a position in EVH in Q2 2022 and held it in 11 quarters. The position peaked at $4.95M in Q3 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

Lombard Odier Asset Management (Europe) reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 175,000 Evolent Health shares in Q1 2025, an estimated $1.97M.
Lombard Odier Asset Management (Europe) first reported a position in Evolent Health in Q2 2022 and held it in 11 quarters.
Lombard Odier Asset Management (Europe)'s Evolent Health position peaked at $4.95M in Q3 2024.
227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2025, filed 15 May 2025.